Showcasing TriGlytza™
A therapeutic approach for B-cell preservation developed by Myopharm.
About the Project
Therapeutic approach for B-cell preservation with TriGlytza™
The objective of this project was to create an engaging animated video for investors that showcased Myopharm’s drug candidate, TriGlytza™, aimed at to addressing the large unmet need caused by type two diabetes treatment failures.
This drug uses a novel mechanism to address progressive beta-cell loss through reducing proinflammatory mediators within the PGE2 signaling pathway.
About Myopharm
Myopharm is developing targeted therapies for multiple chronic diseases, using a multifaceted approach to development.
Myopharm strives to enhance and prolong lives.
Myopharm Limited is a clinical-stage Australian-based biopharmaceutical company, developing targeted therapies for multiple chronic diseases using a multifaceted approach to development.
our works
-
![A digital illustration of a virus attacking blood cells inside a blood vessel, depicting green viruses with spikes, purple cell clusters, and orange blood cells.]()
CAR-T Cell Therapy
-
![A close-up illustration of blood vessels and blood cells with molecules and proteins interacting at the cellular level.]()
Showcasing TriGlytza™
-
![Illustration of multiple 3D DNA double helix strands floating in space with a starry background.]()
DNA Replication Mutations
-
![A science or technology museum exhibit featuring interactive displays with neon lights, digital screens, and people exploring the area.]()
ZAP! - Understanding Electricity
-
![People observing digital interactive art installations with colorful lightning, cosmic images, and abstract visuals in a dark exhibition space.]()
Queensland Museum Science Centre
-
![Colorful exhibit wall with images of scientific research, technology, and people in labs, illuminated with neon lights.]()
Eye and Ear Hospital History Wall
